iX Biopharma Ltd announced that it allotted and issued 1,418,000 new ordinary shares on Dec, 4 2025, following the exercise of warrants at 0.06 Singapore dollars per share.

The issuance increases the company’s total share count to 958,025,610 from 956,607,610.

To date, 3,066,165 warrants, equivalent to 5.33 % of all warrants previously issued, have been exercised. A further 54,443,314 warrants remain outstanding, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.

The new shares are expected to begin trading on the Singapore Exchange on or around Dec, 8 2025.